Skip to content

The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease

The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03833349
Acronym
PDExercise
Enrollment
24
Registered
2019-02-07
Start date
2019-02-11
Completion date
2019-10-02
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease, fatigue, anxiety, depression, exercise

Brief summary

The purpose of the study is to learn about the impact of exercise on fatigue, anxiety, and depression in Parkinson's disease. It is well established that exercise improves the motor symptoms of Parkinson's disease. However, it is not clear which types of exercise are most beneficial for specific non-motor symptoms.

Detailed description

This is a multi-site trial (12 patients in each site). The investigators are recruiting 24 patients who will be randomized into either a spinning class, yoga class, dance class, or no exercise intervention. Classes will be conducted twice a week for 6 weeks total at times convenient for the patients. Patients will also be asked to complete questionnaires after exercise classes to see if the exercise intervention improves measures of fatigue, anxiety, and depression - and what exercise intervention may be superior. All participants will be asked to complete questionnaires each week and will be asked to wear a Microsoft exercise band during the course of the study. Use of the exercise band is optional.

Interventions

BEHAVIORALSpinning Class

Spinning Class twice a week for six weeks.

BEHAVIORALYoga Class

Yoga Class twice a week for six weeks.

BEHAVIORALDance Class

Dance Class twice a week for six weeks.

Sponsors

Parkinson's Disease Foundation
CollaboratorOTHER
Dartmouth-Hitchcock Medical Center
CollaboratorOTHER
Premier Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects diagnosed with Idiopathic Parkinson's Disease 2. Age between 18 - 75 years 3. Hoehn and Yahr stage less than or equal to 3 4. Mini-Mental State Exam (MMSE) score of over 23 at screening 5. If subjects are taking any medications for depression, fatigue, or anxiety, regimen must be stable for 8 weeks prior to baseline visit 6. Subjects willing and able to give informed consent

Exclusion criteria

1. Subjects with a diagnosis of an atypical Parkinsonism 2. Subjects unwilling or unable to obtain Health Waiver from Primary Care Provider 3. Score of 60 or more on UPDRS III at screening 4. Scores in the 'normal' range on all three study assessments: Beck Depression Index II, Fatigue Severity Scale, and Zung self-rating Anxiety Scale 5. Participation in any of the 3 physical activities more than 3 times in the past for 8 weeks prior to baseline 6. Any other reason that, in the investigator's opinion, would exclude the subject from participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline, if any, in subjects' Fatigue Severity Scalescreening through study completion, up to 18 weeksSubjects will complete the Fatigue Severity Scale at screening and once per week during the exercise class session. Subjects also will receive a follow-up questionnaire to be completed 1 month after the class sessions end. Each item is scored from 1(strongly disagree) to 7(strongly agree).
Change from baseline, if any, in subjects' Zung self-report Anxiety Scalescreening through study completion, up to 18 weeksSubjects will complete the Zung self-report Anxiety Scale at screening and once per week during the exercise class session. Subjects also will receive a follow-up questionnaire to be completed 1 month after the class sessions end. Each item is scored from 1(a little of the time) to 4(most of the time).
Change from baseline, if any, in subjects' Beck Depression Inventory II scalescreening through study completion, up to 18 weeksSubjects will complete the Beck Depression Inventory II at screening and once per week during the exercise class session. Subjects also will receive a follow-up questionnaire to be completed 1 month after the class sessions end. Each item is scored from 0(Normal) to 3(Severe).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026